A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023
Djin‐Ye Oh(Robert Koch Institute), Martin Mielke, Sofia Paraskevopoulou(Robert Koch Institute), Stefan Kröger(Robert Koch Institute), Susanne Duwe, Martin Hölzer(Robert Koch Institute), Agata Mikołajewska(Department of Science and Technology), Daniela Börnigen(Broad Institute), Romy Kerber(Robert Koch Institute), Walter Haas(Robert Koch Institute), Sindy Böttcher(Robert Koch Institute), Matthias Budt(Robert Koch Institute), Max von Kleist(Robert Koch Institute), Stephan Fuchs, Thorsten Wolff, Ralf Dürrwald, Janna Seifried
Refubium (Universitätsbibliothek der Freien Universität Berlin)
January 1, 2025
Cited by 0
Related Papers
Discrete populations of isotype-switched memory B lymphocytes are maintained in murine spleen and bone marrow
|Nature Communications|2020|205
Molecular Evolution of Human Adenovirus (HAdV) Species C
|Scientific Reports|2019|159
A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study
|The Lancet Infectious Diseases|2018|156
Circulation of non-polio enteroviruses in 24 EU and EEA countries between 2015 and 2017: a retrospective surveillance study
|The Lancet Infectious Diseases|2019|156
Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research
|Briefings in Bioinformatics|2020|149